Gilde Healthcare and Versant Ventures leads funding round for Lava Therapeutics
Lava Therapeutics, a Dutch biotech company, has raised 16 million euros in funding. Gilde Healthcare and Versant Ventures led the round with participation from MRL Ventures Fund, Lupus Ventures and Biox Biosciences.
23 May 2018•1 min read
